Collaborations and top research areas from the last five years
Profiles
Research output
-
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on ‘real world’ experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm
Rampotas, A., Aspa-Cilleruelo, J. M., Koster, L., Avenoso, D., Passweg, J., Sala, E., Robin, M., Myhre, A. E., de Witte, M., Nur, E., Chevallier, P., Schroeder, T., Srour, M., Chiusolo, P., Salmenniemi, U., Verbeek, M., Finazzi, M. C., Castilla-Llorente, C., Rubio, M. T. & Sobieralski, P. & 9 others, , 2026, In: Bone Marrow Transplantation. 61, 3, p. 333–340 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Downloads (Pure) -
A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma
Rade, M., Fandrei, D., Kreuz, M., Seiffert, S., Grahnert, A., Friedrich, M., Wiemers, T., Born, P., Fischer, L., Weidner, H., Hofbauer, L. C., Baber, R., Wang, S. Y., Bach, E., Hoffmann, S., Scolnick, J., Friedrich, M., Keramati, F., Brazda, P. & Sebestyen, Z. & 16 others, , 9 Mar 2026, In: Cancer Cell. 44, 3, p. 586-603.e9Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Author Correction: Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation
Kimman, T., Cuenca, M., Tieland, R. G., Rockx-Brouwer, D., Janssen, J., Motais, B., Slomp, A., Pleijte, C., Heijhuurs, S., Meringa, A. D., Boschloo, W., Bosma, D. M. T., Kroos, S., Lo Presti, V., Sluijter, J. P. G., Nierkens, S., Bovenschen, N., Kuball, J., van Mil, A. & Minnema, M. C. & 2 others, , 13 Apr 2026, In: Nature Communications. 17, 1, 3442.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open AccessFile1 Downloads (Pure)
Activities
-
Exploring Vγ9Vδ2 T Cells & Receptors
Sebestyen, Z. (Invited speaker)
30 Sept 2020Activity: Talk or presentation › Invited talk › Professional
-
Antibody Engineering and Therapeutics Europe
Leusen, J. (Keynote/plenary speaker) & Kuball, J. (Invited speaker)
10 Jun 2020 → 11 Jun 2020Activity: Participating in or organising an event › Participation in conference › Academic
-
Bureaucratische regels en te weinig geld: Jaagt Nederland toponderzoek het land uit?
Clevers, H. (Interviewee), Fuchs, S. A. (Interviewee), Kuball, J. (Interviewee) & Bredenoord, A. L. (Interviewee)
9 Mar 2020Activity: Other › Types of Public engagement and outreach - Media article or participation
Prizes
-
Dutch Cancer Society/KWF Unique High Risk Project: Empowering the T cell killing machinery to eradicate cancer cells and prevent outgrowth.
Peperzak, V. (Recipient) & Sebestyen, Z. (Recipient), 2018
Prize: Fellowship awarded competitively
-
KWF/Alpe d'HuZes Research Project grant: Optimized Killing (OK) technology to empower engineered T or NK cells in the treatment of cancer.
Peperzak, V. (Recipient) & Sebestyen, Z. (Recipient), 2020
Prize: Fellowship awarded competitively